Wheaton Precious Metals Corp (WPM) Stock Price Today
Aura AI Summary
Key Stats
- $61.60BMarket Cap
- 3,052,598Volume
- Basic MaterialsSector
- $165.7252W High
- $94.3752W Low
- 65 DaysTypical Hold Time
- $63.48BEnterprise Value
- 0.58%Div Yield
- 29% Sell | 71% BuyTrading Activity
Track Wheaton Precious Metals Corp (WPM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Wheaton Precious Metals Corp has traded between a low of $94.37 and a high of $165.72, highlighting its annual price range. Buy and sell Wheaton Precious Metals Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Most Recent News
GameStop insiders buy millions in shares, signaling strong confidence despite stock volatility.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...

Stocks fall as uniQure, Fair Isaac, and ClearPoint Neuro lead losses on clinical and regulatory concerns.
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...

Iovance, SoundThinking, and WidePoint stocks surge on revenue upgrades, acquisition deal, and government contract news
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.